[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK3319970T3 - Pyrido-oxazinonderivater som tnap-hæmmere - Google Patents

Pyrido-oxazinonderivater som tnap-hæmmere Download PDF

Info

Publication number
DK3319970T3
DK3319970T3 DK16775006T DK16775006T DK3319970T3 DK 3319970 T3 DK3319970 T3 DK 3319970T3 DK 16775006 T DK16775006 T DK 16775006T DK 16775006 T DK16775006 T DK 16775006T DK 3319970 T3 DK3319970 T3 DK 3319970T3
Authority
DK
Denmark
Prior art keywords
oxazino
pyrido
derivatives
tnap inhibitors
tnap
Prior art date
Application number
DK16775006T
Other languages
English (en)
Inventor
Shojiro Miyazaki
Yuko Yamamoto
Keisuke Suzuki
Masaharu Inui
Masanori Izumi
Kaori Soma
Anthony Pinkerton
Taeko Shinozaki
Original Assignee
Daiichi Sankyo Co Ltd
Sanford Burnham Prebys Medical Discovery Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd, Sanford Burnham Prebys Medical Discovery Inst filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of DK3319970T3 publication Critical patent/DK3319970T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK16775006T 2015-07-08 2016-07-07 Pyrido-oxazinonderivater som tnap-hæmmere DK3319970T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562190145P 2015-07-08 2015-07-08
PCT/US2016/041345 WO2017007943A1 (en) 2015-07-08 2016-07-07 Pyrido-oxazinone derivatives as tnap inhibitors

Publications (1)

Publication Number Publication Date
DK3319970T3 true DK3319970T3 (da) 2019-12-02

Family

ID=57045381

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16775006T DK3319970T3 (da) 2015-07-08 2016-07-07 Pyrido-oxazinonderivater som tnap-hæmmere

Country Status (28)

Country Link
US (3) US9920068B2 (da)
EP (1) EP3319970B1 (da)
JP (1) JP6666928B2 (da)
KR (1) KR102590067B1 (da)
CN (1) CN107207527B (da)
AU (1) AU2016291163B2 (da)
CA (1) CA2962795C (da)
CO (1) CO2017003830A2 (da)
CY (1) CY1122477T1 (da)
DK (1) DK3319970T3 (da)
ES (1) ES2754480T3 (da)
HK (1) HK1253572A1 (da)
HR (1) HRP20192121T1 (da)
HU (1) HUE046994T2 (da)
IL (1) IL251005B (da)
LT (1) LT3319970T (da)
MX (1) MX2017003822A (da)
MY (1) MY185558A (da)
PH (1) PH12018500066A1 (da)
PL (1) PL3319970T3 (da)
PT (1) PT3319970T (da)
RS (1) RS59594B1 (da)
RU (1) RU2715704C2 (da)
SG (1) SG11201701378WA (da)
SI (1) SI3319970T1 (da)
TW (1) TWI702220B (da)
WO (1) WO2017007943A1 (da)
ZA (1) ZA201701783B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110167946B (zh) * 2016-12-23 2022-04-08 第一三共株式会社 具有tnap抑制活性的磺酰胺化合物
TW201829417A (zh) * 2016-12-23 2018-08-16 日商第一三共股份有限公司 氧氮呯化合物
US11932600B2 (en) 2018-10-23 2024-03-19 Daiichi Sankyo Company Limited Biaryl derivative
CN114085911B (zh) * 2022-01-19 2022-05-17 珠海圣美生物诊断技术有限公司 一种检测肿瘤细胞或肿瘤细胞碎片的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810795A (en) 1982-09-30 1989-03-07 A. H. Robins Company, Incorporated Certain 2,5 and 2,5,6-di- and tri-substituted nicotinic acid intermediates
CA2352612A1 (en) 1998-11-27 2000-06-08 Hideo Fukui Pharmaceuticals
PE20011061A1 (es) * 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
JP2009500442A (ja) 2005-07-09 2009-01-08 アストラゼネカ アクチボラグ 2型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての2−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物
EP2433496A1 (en) 2007-05-08 2012-03-28 Burnham Institute for Medical Research Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
BR112014020773A2 (pt) * 2012-02-22 2020-10-27 Sanford-Burnham Medical Research Institute compostos de sulfonamida e seus usos como inibidores tnap

Also Published As

Publication number Publication date
NZ729387A (en) 2023-12-22
IL251005B (en) 2020-03-31
SG11201701378WA (en) 2018-01-30
KR20180028395A (ko) 2018-03-16
US20180141960A1 (en) 2018-05-24
CY1122477T1 (el) 2021-01-27
HUE046994T2 (hu) 2020-04-28
WO2017007943A1 (en) 2017-01-12
CN107207527B (zh) 2019-10-01
RU2715704C2 (ru) 2020-03-03
JP6666928B2 (ja) 2020-03-18
ES2754480T3 (es) 2020-04-17
TWI702220B (zh) 2020-08-21
US20170240562A1 (en) 2017-08-24
PH12018500066A1 (en) 2018-07-09
LT3319970T (lt) 2019-11-11
BR112017006798A2 (pt) 2018-01-09
TW201713668A (zh) 2017-04-16
US10221195B2 (en) 2019-03-05
EP3319970A1 (en) 2018-05-16
RS59594B1 (sr) 2020-01-31
HRP20192121T1 (hr) 2020-02-21
KR102590067B1 (ko) 2023-10-16
US20170210755A1 (en) 2017-07-27
CO2017003830A2 (es) 2017-08-31
PL3319970T3 (pl) 2020-03-31
HK1253572A1 (zh) 2019-06-21
CA2962795A1 (en) 2017-01-12
RU2017117179A3 (da) 2019-09-24
US9920068B2 (en) 2018-03-20
EP3319970B1 (en) 2019-08-28
IL251005A0 (en) 2017-04-30
US9879032B2 (en) 2018-01-30
AU2016291163B2 (en) 2020-01-23
JP2018522814A (ja) 2018-08-16
MY185558A (en) 2021-05-20
PT3319970T (pt) 2019-11-15
CN107207527A (zh) 2017-09-26
MX2017003822A (es) 2017-06-26
CA2962795C (en) 2019-09-10
AU2016291163A1 (en) 2017-03-16
SI3319970T1 (sl) 2019-12-31
ZA201701783B (en) 2018-12-19
RU2017117179A (ru) 2019-08-08

Similar Documents

Publication Publication Date Title
DK3442980T3 (da) Heterocykliske forbindelser som ret-kinase-hæmmere
DK3371190T3 (da) Heterocykliske forbindelser som pi3k-gamma-inhibitorer
DK3464271T3 (da) Pyrazolderivater som plasma-kallikreininhibitorer
DK3277677T3 (da) 1-cyano-pyrrolidinforbindelser som usp30-hæmmere
DK3377488T3 (da) Heterocykliske forbindelser som immunomodulatorer
DK3302448T3 (da) Erstattede heterocyclylafledninger som cdk-inhibitore
DK3298002T3 (da) Heterocykliske amider som kinasehæmmere
DK3105218T3 (da) Cyclopropylaminer som lsd1-inhibitorer
DK3105226T3 (da) Cyclopropylaminer som lsd1-inhibitorer
DK3319956T3 (da) Substituerede oxopyridinderivater
DK3313832T3 (da) 3-tetrazolyl-benzen-1,2-disulfonamidderivater som metallo-beta- lactamase-hæmmere
DK3786162T3 (da) Bipyrazolderivater som jak-inhibitorer
DK3442972T3 (da) Bromdomænehæmmere
DK3204381T3 (da) N-pyridinylacetamidderivater som wnt-signaleringsbanehæmmere
DK3094631T3 (da) Pyrimidinyloxybenzenderivater som herbicider
BR112016030697A2 (pt) inibidores da desmetilase-1 específica da lisina
DK3271349T3 (da) Benzimidazolederivater som bromodomain-inhibitorer
DK3286177T3 (da) Quinolinderivater som tam rtk-inhibitorer
DK3458460T3 (da) Imidazoler som histondemethylase-inhibitorer
DK3288944T3 (da) Imidazopyrazinoner som pde1-inhibitorer
DK3116475T3 (da) Dopa-decarboxylasehæmmersammensætninger
DK3186242T3 (da) Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere
DK3544981T3 (da) Benzodiazoliumforbindelser som enac-inhibitorer
DK3341379T3 (da) EZH2-hæmmere
DK3114120T3 (da) Tetrazolon-substituerede dihydropyridinon-mgat2-hæmmere